reference/8029980

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8029980

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1465-542X 1465-5411
issueIdentifier	2
pageRange	r66-
publicationName	Breast cancer research : BCR
startingPage	r66
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5d6d95f905a896550f70a84795a07c51 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2be682f4d77cca1a3e88008f4c6f25ce http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_767a64b64be3477b79b0a48271f1624f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ecf070296e9fcd6ef23423a9fcdf9c66 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1138734756da69da8f61c0793c4fbea7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_26dadfdca5449a4a68a446d81c826cc4
bibliographicCitation	Borges S, Döppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, Thompson E, Geiger XJ, Storz P. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Breast Cancer Res. 2013 Aug 23;15(2):R66. PMID: 23971832; PMCID: PMC4052945.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdcf69b279f4c20046cac262413ddf5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9f6e8573e88c63dc7e47cfb464c4b58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc8d7cba2230a6b248cccd9e8ccedccc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8461-7523 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23254438ac99b9a9c66ab2ba7d701c67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb61651bf7a2f7a75d2f99825020d513 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af3f1cf179146f68413eb03fe6737824 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2533d192c551a2151d87555f7c8acc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cf184ce475ba642ceefb7f47ae0535a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae37d61df75d0c84729eab74ad7621bb
date	2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/23971832 https://pubmed.ncbi.nlm.nih.gov/PMC4052945 https://doi.org/10.1186/bcr3460
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884 https://portal.issn.org/resource/ISSN/1465-5411 https://portal.issn.org/resource/ISSN/1465-542X
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis
discusses	http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0062824 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0002060 http://id.nlm.nih.gov/mesh/M0017861 http://id.nlm.nih.gov/mesh/M0235890
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10186 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d628a25e892b9935143372f9882c544 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104748 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7164 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.1.1.37 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10184 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_191bbce6ddc4cb89d91ad4461c15e164

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5587

Total number of triples: 60.